Lancashire and South Cumbria
Formulary
10 Musculoskeletal and joint diseases
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
10-02-02 Nocturnal leg cramps
Quinine
Formulary
Tablets 200mg, 300mg
MHRA: Quinine: reminder of dose-dependent QT-prolonging effects; updated medicine interactions
Quinine for muscle cramps
Links
Cochrane review of the evidence
EMSCG Commissioning policy for Intrathecal Baclofen (ITB)
LSCMMG: Gastroenterology Biologics Pathway
LSCMMG: Primary Care Constipation Guidelines
MHRA Drug Safety Update Nov 2017: Quinine: reminder of dose-dependent QT-prolonging effects; updated medicine interactions
MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
MHRA: Quinine: reminder of dose-dependent QT-prolonging effects; updated medicine interactions
NICE CG147: Diverticular disease: diagnosis and management
NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
NICE HST15: Onasemnogene abeparvovec for treating spinal muscular atrophy
NICE HST24: Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy
NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
NICE NG144: Cannabis-based medicinal products
NICE NG144:Cannabis-based medicinal products
NICE NST22 Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene
NICE TA588: Nusinersen for treating spinal muscular atrophy
NICE TA588: Nusinersen for treating spinal muscular atrophy
NICE TA748: Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
NICE TA748: Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
NICE TA755: Risdiplam for treating spinal muscular atrophy
NICE TA755:Risdiplam for treating spinal muscular atrophy
NICE: Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy
NICE: Onasemnogene abeparvovec for treating spinal muscular atrophy
NICE:Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene
Quinine for muscle cramps
Key
Full Site